Izilendustat is a potent inhibitor of prolyl hydroxylase which can stabilize hypoxia inducible factor- 1 alpha (HIF- lalpha) and hypoxia inducible factor-2 (HIF-2). Izilendustat has the potential for researching diseases that relate to the bodys inmmune response like colitis and other inflammatory bowel diseases (extracted from patent WO2011057115A1 and WO2011057121A1)[1][1].
Molekulargewicht:
433.94
Reinheit:
98.01
CAS Nummer:
[1303512-02-8]
Formel:
C22H28ClN3O4
Target-Kategorie:
HIF/HIF Prolyl-Hydroxylase
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten